Effects of diethylpropion treatment and withdrawal on aorta reactivity, endothelial factors and rat behavior

Toxicology and Applied Pharmacology

Volumn 190, Issue 2, 2003, Pages 170-176

  Borges Bispo Da Silva, Luiz ^a   Cordellini, Sandra ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Behavior; Diethylpropion; Endothelium; Nitric oxide; Reactivity of rat aorta; Treatment; Withdrawal

Indexed keywords

AMFEPRAMONE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BEHAVIOR; BEHAVIORAL SCIENCE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENDOTHELIUM; ENDOTHELIUM CELL; GROOMING; LOCOMOTION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PROSTAGLANDIN SYNTHESIS; RAT; WITHDRAWAL SYNDROME;

EID: 0038826779     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(03)00160-1     Document Type: Article

References (32)

1. Bray G.A. A concise review on the therapeutics of obesity. Nutrition. 16:2000;953-960.
2. Broadhurst P.L. Experiments in psychogenetics. Eysenk H.J. Experiments in Personality. 1960;31-61 Rutledge and Kegan Paul Press, London, UK.
3. Carney M.W. Diethylpropion and psychosis. Clin. Neuropharmacol. 11:1988;183-188.
4. Cordellini S., Vassilief V.S. Decreased endothelium-dependent vasoconstriction to noradrenaline in acute-stressed rats is potentiated by previous chronic stress nitric oxide involvement . Gen. Pharmacol. 30:1998;79-83.
5. Cordellini S., Carvalho M.H.C., Scivoletto R., Fortes Z.B., Nigro D. Indirect evidence for an endothelium-derived contracting factor release in aorta of deoxycorticosterone acetate-salt hypertensive rats. J. Hypertens. 8:1990;53-60.
6. Cunha J.M., Masur J. Evaluation of psychotropic drugs with a modified open field test. Pharmacology. 16:1978;259-267.
7. 1-adrenoceptors following aortic barodenervation. Eur. J. Pharmacol. 337:1997;235-243.
8. Follows O.J. A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients. Br. J. Clin. Pract. 25:1971;236-238.
9. Galvan-Arzate S., Santamaria A. Neurotoxicity of diethylpropion neurochemical and behavioral findings in rats . Ann. NY Acad. Sci. 965:2002;214-224.
10. Gaytan O., Swann A., Dafny N. Diurnal differences in rat's motor response to amphetamine. Eur. J. Pharmacol. 345:1998;119-128.
11. Gevaerd M.S., Sultowski E.T., Takahashi R.N. Combined effects of diethylpropion and alcohol on locomotor activity of mice participation of the dopaminergic and opioid systems . Braz. J. Med. Biol. Res. 32:1999;1545-1550.
12. Hiremath A.N., Hu Z.-W., Hoffman B.B. Desensibilization of α-adrenergic receptor-mediated smooth muscle contraction role of endothelium . J. Cardiovasc. Pharmacol. 18:1991;151-157.
13. Hu Z.W., Honda K., Murad F., Hoffman B.B. Prolonged exposure to catecholamines enhances sensitivity of smooth muscle relaxation induced by sodium nitroprusside and atriopeptin. J. Pharmacol. Exp. Ther. 260:1992;756-761.
14. Jasinski D.R., Nutt J.G., Griffith J.D. Effects of diethylpropion and d-amphetamine after subcutaneous and oral administration. Clin. Pharmacol. Ther. 16:1974;645-665.
15. Joannides R., Richard V., Haefeli W.E., Benoist A., Linder L., Lüscher T.F., Thuillez C. Role of nitric oxide in the regulation of the mechanical properties of peripheral conduit arteries in humans. Hypertension. 30:1997;1465-1470.
16. Kelm M., Feelisch M., Krebber T., Motz W., Strauer B.E. The role of nitric oxide in the regulation of coronary vascular resistance in arterial hypertension comparison of normotensive and spontaneously hypertensive rats . J. Cardivasc. Pharmacol. 20:1992;S183-S186.
17. Kelm M., Feelisch M., Krebber T., Deussen A., Motz W., Strauer B.E. Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide . Hypertension. 25:1995;186-193.
18. Leith N.J., Kuczenski R. Chronic amphetamine tolerance and reverse tolerance reflect different behavioral actions of the dog . Pharmacol. Biochem. Behav. 15:1981;399-405.
19. Levine R.R., Walsh C.T., Schawartz-Bloom R.D. The pharmacologic aspects of drug abuse and drug dependence. Levine R.R., Walsh C.T., Schawartz-Bloom R.D. Pharmacology Drug Actions and Reactions . 2000;407-410 Parthenon Press, New York.
20. Lynch M.A., Leonard B.E. Effect of chronic amphetamine administration on the behavior of rats in the open field apparatus reversal of post-withdrawal depression by two antidepressants . J. Pharm. Pharmacol. 30:1978;798-799.
21. Navarro-Oliveira C.M., Vassilieff V.S., Cordellini S. The sympathetic adrenomedullary system, but not the hypothalamic-pituitary-adrenal axis, participates in aorta adaptive response to stress nitric oxide involvement . J. Auton. Nerv. Syst. 83:2000;140-147.
22. Planeta C.S., DeLucia R. Involvement of dopamine receptors in diethylpropion-induced conditioning place preference. Braz. J. Med. Biol. Res. 31:1998;561-564.
23. Pulvirenti L., Koop G.F. Lisuride reduces psychomotor retardation during withdrawal from chronic intravenous amphetamine self-administration in rats. Neuropsychopharmacology. 8:1993;213-218.
24. Rees D.D., Palmer R.M.J., Schulz R., Hodson H.F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101:1990;746-752.
25. Reimer A.R., Martin-Iverson M.T., Urichuk L.J., Coutts R.T., Byrne A. Conditioned place preference, conditioned locomotion, and behavioral sensitization occur in rats treated with diethylpropion. Pharmacol. Biochem. Behav. 51:1995;89-96.
26. Safta L., Cuparencu B. Cardiovascular effects of amphepramone. Physiologie. 15:1978;117-125.
27. Safta L., Cuparencu B., Sîrbu A., Secareanu A.L. Experimental observation on the effect of amphepramone on behavior, locomotion, pentetrazol seizures and eletroencephalogram. Psychopharmacology. 50:1976;165-169.
28. Topp L., Darke S. The applicability of the dependence syndrome to amphetamine. Drug Alcohol Depend. 48:1997;113-118.
29. 2 dopamine systems in the behavioral effects of cocaine in rats. Pharmacol. Biochem. Behav. 52:1995;737-741.
30. Vane J.R. Inhibition of prostaglandin synthase as a mechanism of action for aspirin-like drugs. Nat. New Biol. 23:1971;232-235.
31. Vargas H.M., Ignarro L.J., Gaudhuri G. Physiological release of nitric oxide is dependent on the level of vascular tone. Eur. J. Pharmacol. 190:1990;393-397.
32. Yu H., Rothman R.B., Dersch C.M., Partilla J.S., Rice K.C. Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters. Bioorg. Med. Chem. 8:2000;2689-2692.